You are here
Home > News > EMA calls extraordinary meeting on AstraZeneca vaccine

EMA calls extraordinary meeting on AstraZeneca vaccine

The European Medicines Agency (EMA) announced that it will hold an extraordinary meeting on Thursday regarding the reports of alleged side effects of the AstraZeneca vaccine.

The agency will summarise the findings so far and make decisions on further actions over the vaccine.

The announcement follows the decision to suspend vaccination with AstraZeneca products taken by multiple countries as a precaution due to a number of events of blood clots in people who had received the vaccine.

The list of countries that have stopped administering AstraZeneca includes ,among others, Germany, France, Italy, Spain, Denmark, Norway, Ireland, the Netherlands and Indonesia.

The EMA is to review the reports on the jab and carry out a rigorous analysis of thromboembolic data. The agency wants to verify whether the AstraZeneca vaccine may have contributed to the reported blood clots events.

The EMA emphasised that such cases have so far occurred in a very small number of vaccinated people.

Warning: Invalid argument supplied for foreach() in /var/www/warsawpoint/data/www/ on line 69

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.